title: Segmental versican expression in the trabecular meshwork and involvement in outflow facility.
abstract: OBJECTIVE
  Versican is a large proteoglycan with numerous chondroitin sulfate (CS) glycosaminoglycan (GAG) side chains attached. To assess versican's potential contributions to aqueous humor outflow resistance, its segmental distribution in the trabecular meshwork (TM) and the effect on outflow facility of silencing the versican gene were evaluated.
  
  
  METHODS
  Fluorescent quantum dots (Qdots) were perfused to label outflow pathways of anterior segments. Immunofluorescence with confocal microscopy and quantitative RT-PCR were used to determine versican protein and mRNA distribution relative to Qdot-labeled regions. Lentiviral delivery of shRNA-silencing cassettes to TM cells in perfused anterior segment cultures was used to evaluate the involvement of versican and CS GAG chains in outflow facility.
  
  
  RESULTS
  Qdot uptake by TM cells showed considerable segmental variability in both human and porcine outflow pathways. Regional levels of Qdot labeling were inversely related to versican protein and mRNA levels; versican levels were relatively high in sparsely Qdot-labeled regions and low in densely labeled regions. Versican silencing decreased outflow facility in human and increased facility in porcine anterior segments. However, RNAi silencing of ChGn, an enzyme unique to CS GAG biosynthesis, increased outflow facility in both species. The fibrillar pattern of versican immunostaining in the TM juxtacanalicular region was disrupted after versican silencing in perfusion culture.
  
  
  CONCLUSIONS
  Versican appears to be a central component of the outflow resistance, where it may organize GAGs and other ECM components to facilitate and control open flow channels in the TM. However, the exact molecular organization of this resistance appears to differ between human and porcine eyes.
authors: Casey Eye Institute, Oregon Health and Science University, Portland, Oregon 97239, USA.
authors: Kate E
authors: KE
authors: Keller
authors: John M
authors: JM
authors: Bradley
authors: Janice A
authors: JA
authors: Vranka
authors: Ted S
authors: TS
authors: Acott
references: Invest Ophthalmol Vis Sci. 2005 Jan;46(1):1-7
references: 15623746
references: Invest Ophthalmol Vis Sci. 1989 Oct;30(10):2215-31
references: 2793361
references: Invest Ophthalmol Vis Sci. 2008 Jun;49(6):2495-505
references: 18515587
references: Exp Eye Res. 1986 May;42(5):443-55
references: 3720863
references: Invest Ophthalmol Vis Sci. 2002 Apr;43(4):1068-76
references: 11923248
references: Invest Ophthalmol Vis Sci. 2006 Oct;47(10):4181-7
references: 17003404
references: Exp Eye Res. 2009 Apr;88(4):656-70
references: 19103197
references: Invest Ophthalmol Vis Sci. 1994 Oct;35(11):3841-51
references: 7928181
references: Invest Ophthalmol Vis Sci. 1988 Jan;29(1):90-100
references: 3335436
references: Invest Ophthalmol Vis Sci. 2002 Jul;43(7):2196-200
references: 12091416
references: J Biol Chem. 2007 Feb 9;282(6):4152-61
references: 17145758
references: Invest Ophthalmol Vis Sci. 2008 Dec;49(12):5353-65
references: 18641286
references: Exp Eye Res. 1992 Nov;55(5):691-709
references: 1478279
references: Circ Res. 2006 Feb 17;98(3):370-7
references: 16385080
references: Invest Ophthalmol Vis Sci. 2004 Nov;45(11):4023-34
references: 15505052
references: Exp Eye Res. 1992 Jun;54(6):879-83
references: 1521580
references: Invest Ophthalmol Vis Sci. 2001 Jul;42(8):1795-802
references: 11431444
references: Invest Ophthalmol Vis Sci. 1984 Mar;25(3):286-93
references: 6698747
references: Invest Ophthalmol. 1975 Mar;14(3):173-6
references: 123231
references: Invest Ophthalmol Vis Sci. 2000 Sep;41(10):2984-90
references: 10967055
references: IUBMB Life. 2002 Oct;54(4):177-86
references: 12512856
references: Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1692-7
references: 19060275
references: J Biol Chem. 2003 Jan 31;278(5):3072-8
references: 12433924
references: Invest Ophthalmol Vis Sci. 2011 Jan 05;52(1):45-50
references: 20720231
references: Invest Ophthalmol Vis Sci. 1996 Nov;37(12):2414-25
references: 8933758
references: Invest Ophthalmol Vis Sci. 2001 Jun;42(7):1505-13
references: 11381054
references: J Biol Chem. 2002 Mar 15;277(11):8841-6
references: 11788602
references: Invest Ophthalmol Vis Sci. 2009 Dec;50(12):5769-77
references: 19553617
references: Exp Eye Res. 2002 Feb;74(2):161-72
references: 11950226
references: Arch Ophthalmol. 1989 Apr;107(4):572-6
references: 2705927
references: Exp Eye Res. 2009 Apr;88(4):676-82
references: 19087875
references: Invest Ophthalmol Vis Sci. 2008 Dec;49(12):5346-52
references: 18515571
references: Exp Eye Res. 2008 Feb;86(2):271-81
references: 18155193
references: Am J Ophthalmol. 1972 May;73(5):760-89
references: 4623937
references: J Biol Chem. 2002 Oct 11;277(41):38189-96
references: 12163485
references: Invest Ophthalmol Vis Sci. 1996 Jun;37(7):1360-7
references: 8641839
references: Mol Ther. 2008 Jan;16(1):97-106
references: 17912236
references: Exp Eye Res. 1978 Nov;27(5):567-75
references: 720430
references: Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1164-72
references: 17325160
references: Invest Ophthalmol Vis Sci. 2006 Jan;47(1):226-34
references: 16384967
references: Arch Ophthalmol. 1992 Jan;110(1):110-7
references: 1731702
references: J Glaucoma. 2005 Jun;14(3):230-8
references: 15870607
references: Invest Ophthalmol Vis Sci. 1981 Oct;21(4):563-73
references: 7287346
references: Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5768-75
references: 20574017
references: Invest Ophthalmol Vis Sci. 1998 Jul;39(8):1361-71
references: 9660484
references: Hum Gene Ther. 2001 Nov 20;12(17):2109-19
references: 11747600
references: J Glaucoma. 1993 Summer;2(2):80-6
references: 19920491
references: Exp Eye Res. 2006 Apr;82(4):545-57
references: 16386733
references: Exp Eye Res. 2009 Apr;88(4):769-75
references: 19114037
references: Invest Ophthalmol Vis Sci. 2003 Dec;44(12):5174-81
references: 14638714
references: Curr Opin Cell Biol. 2002 Oct;14(5):617-23
references: 12231358
references: Invest Ophthalmol Vis Sci. 2004 Jan;45(1):153-8
references: 14691167
references: Glycobiology. 2004 Jul;14(7):621-33
references: 15044391
references: J Biol Chem. 1992 May 15;267(14):10003-10
references: 1577773
references: Invest Ophthalmol Vis Sci. 1998 Dec;39(13):2649-58
references: 9856774
references: Curr Eye Res. 1997 May;16(5):412-21
references: 9154378
references: Surv Ophthalmol. 1996 Mar-Apr;40(5):379-90
references: 8779084
references: Ophthalmology. 1984 Jun;91(6):564-79
references: 6462622
references: Invest Ophthalmol Vis Sci. 2005 Aug;46(8):2857-68
references: 16043860
references: Exp Eye Res. 2008 Apr;86(4):543-61
references: 18313051
references: Acta Physiol Scand. 1955;33(2-3):257-90
references: 14387768
references: Prog Retin Eye Res. 1999 Jan;18(1):91-119
references: 9920500
references: J Physiol. 2003 Dec 1;553(Pt 2):335-43
references: 12923209
references: Mol Vis. 2005 Aug 12;11:603-8
references: 16110303
references: Exp Eye Res. 1997 Aug;65(2):177-90
references: 9268586